1890 related articles for article (PubMed ID: 18215617)
21. Control of the blood-brain barrier by glucocorticoids and the cells of the neurovascular unit.
Kröll S; El-Gindi J; Thanabalasundaram G; Panpumthong P; Schrot S; Hartmann C; Galla HJ
Ann N Y Acad Sci; 2009 May; 1165():228-39. PubMed ID: 19538311
[TBL] [Abstract][Full Text] [Related]
22. Tight junctions in brain barriers during central nervous system inflammation.
Coisne C; Engelhardt B
Antioxid Redox Signal; 2011 Sep; 15(5):1285-303. PubMed ID: 21338320
[TBL] [Abstract][Full Text] [Related]
23. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.
Sweeney MD; Sagare AP; Zlokovic BV
Nat Rev Neurol; 2018 Mar; 14(3):133-150. PubMed ID: 29377008
[TBL] [Abstract][Full Text] [Related]
24. Blood-Brain Barrier: From Physiology to Disease and Back.
Sweeney MD; Zhao Z; Montagne A; Nelson AR; Zlokovic BV
Physiol Rev; 2019 Jan; 99(1):21-78. PubMed ID: 30280653
[TBL] [Abstract][Full Text] [Related]
25. Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown.
Yeung D; Manias JL; Stewart DJ; Nag S
Acta Neuropathol; 2008 Jun; 115(6):635-42. PubMed ID: 18357461
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound, microbubbles and the blood-brain barrier.
Meairs S; Alonso A
Prog Biophys Mol Biol; 2007; 93(1-3):354-62. PubMed ID: 16959303
[TBL] [Abstract][Full Text] [Related]
27. How neuroinflammation contributes to neurodegeneration.
Ransohoff RM
Science; 2016 Aug; 353(6301):777-83. PubMed ID: 27540165
[TBL] [Abstract][Full Text] [Related]
28. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
Correale J; Villa A
Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
[TBL] [Abstract][Full Text] [Related]
29. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.
Zlokovic BV
Nat Rev Neurosci; 2011 Nov; 12(12):723-38. PubMed ID: 22048062
[TBL] [Abstract][Full Text] [Related]
30. Protein components of the blood-brain barrier (BBB) in the brainstem area postrema-nucleus tractus solitarius region.
Maolood N; Meister B
J Chem Neuroanat; 2009 May; 37(3):182-95. PubMed ID: 19146948
[TBL] [Abstract][Full Text] [Related]
31. Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration.
Salmina AB; Kharitonova EV; Gorina YV; Teplyashina EA; Malinovskaya NA; Khilazheva ED; Mosyagina AI; Morgun AV; Shuvaev AN; Salmin VV; Lopatina OL; Komleva YK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925080
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Disease: astrocytes in neurodegenerative disease.
Maragakis NJ; Rothstein JD
Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
[TBL] [Abstract][Full Text] [Related]
33. Neurovascular mechanisms of Alzheimer's neurodegeneration.
Zlokovic BV
Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
[TBL] [Abstract][Full Text] [Related]
34. Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?
Thompson A; Boekhoorn K; Van Dam AM; Lucassen PJ
Genes Brain Behav; 2008 Feb; 7 Suppl 1():28-42. PubMed ID: 18184368
[TBL] [Abstract][Full Text] [Related]
35. Calcium ions in neuronal degeneration.
Wojda U; Salinska E; Kuznicki J
IUBMB Life; 2008 Sep; 60(9):575-90. PubMed ID: 18478527
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis.
Hoffman WH; Stamatovic SM; Andjelkovic AV
Brain Res; 2009 Feb; 1254():138-48. PubMed ID: 19103180
[TBL] [Abstract][Full Text] [Related]
37. Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: relationship to S-100B levels and blood-brain barrier function.
Gressner OA; Schifflers MC; Kim P; Heuts L; Lahme B; Gressner AM
Clin Chim Acta; 2009 Feb; 400(1-2):86-90. PubMed ID: 19000909
[TBL] [Abstract][Full Text] [Related]
38. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
[TBL] [Abstract][Full Text] [Related]
39. The dynamic blood-brain barrier.
Keaney J; Campbell M
FEBS J; 2015 Nov; 282(21):4067-79. PubMed ID: 26277326
[TBL] [Abstract][Full Text] [Related]
40. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis.
McQuaid S; Cunnea P; McMahon J; Fitzgerald U
Biochem Soc Trans; 2009 Feb; 37(Pt 1):329-31. PubMed ID: 19143657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
